Fundraising FoxVersant Venture AIV Holdings — Full Portfolio
14 tracked investments · listed companies and verified rows first
Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions.
BiotechHealthtechMedical DevicesIrvine, US
Donald E. Bobo, Jr.(Executive Officer)inScott B. Ullem(Executive Officer)inLarry L. Wood(Executive Officer)inHuimin Wang(Executive Officer)inCatherine M. Szyman(Executive Officer)Bernard Zovighian(Director and Chief Executive Officer)in
Board seatWilliam J. Link· per SEC Form D · $272.4M raise · filed Feb 2017
Co-investorsALIVE Israel HealthTech FundPeregrine Ventures
Lensar designs and markets laser systems for cataract surgery and corneal astigmatism correction, offering products that incorporate imaging and precision-guidance technologies to help surgeons achieve consistent visual outcomes.
HealthtechOrlando, US
Randy W Frey(Director)Alan B Connaughton(Executive Officer)inAmy R Brooks(Executive Officer)Peter J Mariani(Executive Officer)Keith H Edwards(Executive Officer)Ronald D Goldrich(Executive Officer)
Board seatWilliam J. Link· per SEC Form D · $20M raise · filed May 2023
Co-investorsAisling Capital
RxSight is an ophthalmic medical technology company that developed the Light Adjustable Lens (LAL), an intraocular lens that can be customized after cataract surgery to optimize a patient's vision.
HardwareHealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRon Kurtz(Chief Medical Officer (former President & CEO))Mark Wilterding(Chief Financial Officer)in
Board seatWilliam Link· per SEC Form D · $77.5M raise · filed Apr 2017
Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA Capital+2 more
Vivani develops miniaturized, long-acting subdermal drug implants using its NanoPortal technology to deliver steady doses of medication over months, addressing medication adherence challenges in chronic disease.
BiotechHealthtechMedical DevicesSylmar, US
ALFRED MANN(Director)ROBERT GREENBERG(Executive Officer, Director)inEdward Sedo(Acting Chief Accounting Officer)Scott Dunbar(Acting CEO)KATHY LONDON(Executive Officer)Adam Mendelsohn(CEO)
Board seatWilliam Link· per SEC Form D · $5M raise · filed Aug 2018
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)
BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)
Board seatWilliam J. Link· per SEC Form D · $2M raise · filed Aug 2016
Co-investorsEvidity Health CapitalFlying L PartnersRevelation PartnersWestern Technology InvestmentHEALTHCARE ROYALTY PARTNERSSV Life Sciences+1 more
BiotechSan Juan Capistrano, US
Hampar Karageozian(Member of Board of Managers and Chief Executive Officer)inVicken Karageozian(Member of Board of Managers and Chief Technical Officer)inJohn Park(Executive Officer, Director)inMarc D. Kirshbaum(Member of Board of Managers and Chief Operating Officer)in
BoardA. Thomas Bender(Member of Board of Managers)Robert Byrnes(Member of Board of Managers)
Board seatWilliam LinkWilliam J. Link· per SEC Form D · $13.5M raise · filed Jan 2019
HealthtechSioux Falls, US
TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)
BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)
Board seatWilliam Link· per SEC Form D · $22M raise · filed Sep 2019
Co-investorsFlying L Partners
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardAli Behbahani(Director)in
Board seatWilliam J Link· per SEC Form D · $43.1M raise · filed Oct 2017
Co-investorsFlying L PartnersNew Enterprise Associates (NEA)Versant VenturesVida Ventures
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)in
BoardJeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Board seatWilliam Link· per SEC Form D · $4.6M raise · filed May 2017
Co-investorsFlying L PartnersVisionary Ventures
ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma.
Deep TechHealthtechMedical DevicesAliso Viejo, US
Tibor Juhasz(Executive Officer, Director)inRick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)inShawn O'Neil(Executive Officer)in
Board seatWilliam Link· per SEC Form D · $8.1M raise · filed Apr 2019
Co-investorsArboretum VenturesClarevia Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
eyeBrain MedicalOneFocus VisionPrelude CorpSightlife Surgical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.